Post

The mesoporous silica support gave 2x higher catalyst turnover frequency.

Our continuous crystallization platform achieved consistent CSD control.

Cell-free protein synthesis achieved gram-per-liter titers for our target protein.

The telescoped synthesis eliminated isolation of the unstable diazo intermediate.

The in vivo PK showed oral bioavailability of 64% in Sprague-Dawley rats.